Villalba Noel Lorenzo, Zulfiqar Abrar-Ahmad, Saint-Mezard Vanessa, Ortiz Maria Belen Alonso, Kechida Melek, Zamorano Nuria Fuertes, Ortega Saturnino Suárez
Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Service d'Endocrinologie, Centre Hospitalier Agen, France.
Pan Afr Med J. 2019 Sep 3;34:7. doi: 10.11604/pamj.2019.34.7.19164. eCollection 2019.
Myxedema coma is a rare complication of hypothyroidism. Clinical examination may reveal hypotension, bradycardia, and hypothermia. Laboratory tests may show hyponatremia, lipid disorders, and elevations of creatine kinase, liver, and cardiac enzymes. We describe four cases diagnosed in our hospital during the period 1999-2017. The patients were related to amiodarone treatment, noncompliance with hormone replacement therapy, or a new diagnosis of hypothyroidism. Intravenous hormone replacement therapy was effective in three of the cases and one died. The outcome of this disease may be fatal as seen in one of our cases.
黏液性水肿昏迷是甲状腺功能减退症的一种罕见并发症。临床检查可能发现低血压、心动过缓及体温过低。实验室检查可能显示低钠血症、脂质紊乱以及肌酸激酶、肝功能和心肌酶升高。我们描述了1999年至2017年期间在我院确诊的4例病例。这些患者与胺碘酮治疗、未坚持激素替代治疗或新发甲状腺功能减退症有关。静脉激素替代治疗在3例病例中有效,1例死亡。正如我们其中1例病例所示,该病的预后可能是致命的。